financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Shares Of West Pharmaceutical Services, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Shares Of West Pharmaceutical Services, Inc.
Apr 25, 2024 9:08 AM

11:55 AM EDT, 04/25/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain a 12-month target price of $375, based on a 2025 P/E of 40.8x, a discount to WST's five-year forward average P/E of 47.0x. We maintain our adjusted EPS estimates of $7.65 for 2024 and $9.20 for 2025. WST posted Q1 EPS of $1.56 vs. $1.98 (-21%), well ahead of the $1.29 consensus. The beat was driven by stronger-than-forecasted sales and margins, as revenue fell 3% to $695M ($20M ahead of consensus) and gross margin contracted 480 bps to 33.1% (110 bps ahead of consensus). WST maintained 2024 revenue guidance of $3.000B-$3.025B, but raised adjusted EPS guidance to $7.63-$7.88 from $7.50-$7.75; the current consensus forecasts are $3.01B and $7.62, respectively. The company reiterated its expectation for stronger organic sales growth in the second half of the year, but we continue to believe caution is warranted, with the stock's valuation appearing fair and near-term comps likely to remain difficult. We maintain a Hold opinion on WST shares, seeing better opportunities across the space.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Buy Opinion On Labcorp Holdings Inc.
Research Alert: CFRA Maintains Buy Opinion On Labcorp Holdings Inc.
Jul 25, 2025
03:25 PM EDT, 07/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target to $316 from $276, 17.9x our 2027 EPS forecast, a premium to historical due to a higher expected growth outlook. We lift our 2025 EPS...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Las Vegas Sands
Research Alert: CFRA Maintains Hold Opinion On Shares Of Las Vegas Sands
Jul 25, 2025
04:05 PM EDT, 07/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month price target by $5 to $55, based on 11x our 2025 adjusted EBITDA estimate and slightly lower than the company's three-year average forward EV/EBITDA multiple. We...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Sonic Automotive Inc.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Sonic Automotive Inc.
Jul 25, 2025
12:20 AM EDT, 07/25/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain a 12-month target of $85, based on a 2026 P/E of 11.5x, a premium to historic averages justified by early-cycle market conditions. We raise our adjusted EPS estimates...
Research Alert: CFRA Lifts Opinion On Shares Of Mobileye Global Inc. To Strong Buy From Buy
Research Alert: CFRA Lifts Opinion On Shares Of Mobileye Global Inc. To Strong Buy From Buy
Jul 25, 2025
02:50 PM EDT, 07/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our target price by $1 to $21, 41x our 2026 EPS estimate, in line with MBLY's three-year average (~41x) as elevated industry uncertainty and slowing EV demand are...
Copyright 2023-2025 - www.financetom.com All Rights Reserved